SM
AMGN icon

SG3 Management’s Amgen AMGN Stock Holding History

SG3 Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48,000
Closed -$10.8M – 936
2021
Q4 		$10.8M Buy
+48,000
New +$10.1M 0.22% 86
2021
Q3 		– Sell
-32,000
Closed -$7.37M – 968
2021
Q2 		$7.8M Buy
+32,000
New +$7.87M 0.28% 77
2017
Q3 		– Sell
-2,500
Closed -$431K – 172
2017
Q2 		$431K Buy
+2,500
New +$407K 0.11% 146

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SG3 Management's AMGN Position: Q1 2022 in Review

SG3 Management sold out of Amgen (AMGN) in Q1 2022, closing a stake of 48,000 shares — an estimated $10.8M sold.

SG3 Management first reported a position in AMGN in Q2 2017 and held it in 3 quarters. The position peaked at $10.8M in Q4 2021. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • SG3 Management reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • SG3 Management sold 48,000 Amgen shares in Q1 2022, an estimated $10.8M.
  • SG3 Management first reported a position in Amgen in Q2 2017 and held it in 3 quarters.
  • SG3 Management's Amgen position peaked at $10.8M in Q4 2021.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on SG3 Management's 13F filing for Q1 2022, filed 16 May 2022.